Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2015-05-19Clinical Trial Update: Aliskiren vs Hydrochlorothiazide in Hypertensive Type II Diabetic Patients on Resistance Arteries [Phase 2]
A Phase 2 trial comparing aliskiren versus hydrochlorothiazide in patients with hypertension and type 2 diabetes has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-05-19Clinical Trial Update: Losartan Versus Hydrochlorothiazide in Reversing Remodeling of Small Arteries in Pre-Hypertensive Pre-Diabetic Subjects [Phase 2]
Phase 2 trial comparing losartan to hydrochlorothiazide in adults with pre-hypertension and pre-diabetes; the study status has been terminat…
-
CLINICAL_TRIALS withdrawal · 2015-05-08Clinical Trial Update: Project Wellness: Increasing HIV Testing Among West African Immigrants [NA]
The clinical trial 'Project Wellness: Increasing HIV Testing Among West African Immigrants' (NCT01270061) has been withdrawn. The study refe…
-
CLINICAL_TRIALS withdrawal · 2015-04-16Clinical Trial Update: Aliskiren Study of Safety and Efficacy in Senior Hypertensives [Phase 4]
Novartis has withdrawn a Phase 4 trial evaluating aliskiren for safety and efficacy in senior hypertensive patients. The study has been disc…
-
CLINICAL_TRIALS withdrawal · 2015-03-25Clinical Trial Update: Chlorthalidone Compared to Hydrochlorothiazide on Endothelial Function [Phase 4]
A Phase 4 trial comparing chlorthalidone versus hydrochlorothiazide for endothelial function in hypertension has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2015-03-17Clinical Trial Update: Sympathetic Nerve Activity in Renal Failure [Phase 4]
A Phase 4 clinical trial examining sympathetic nerve activity in chronic kidney disease with hypertension has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-01-09Clinical Trial Update: A Drug Interaction Study of Boceprevir in Combination With Amlodipine or Diltiazem in Healthy Volunteers [Phase 1]
Phase 1 drug interaction study of Boceprevir with amlodipine or diltiazem in healthy volunteers has been withdrawn.
-
EMA withdrawal · 2014-12-19EMA Withdrawn: Ipreziv (azilsartan medoxomil) — Takeda Pharma A/S
The EMA has withdrawn Ipreziv (azilsartan medoxomil) from the European market for hypertension.
-
CLINICAL_TRIALS withdrawal · 2014-08-05Clinical Trial Update: Study of the Efficacy and Safety of LCZ696 Alone and in Combination With Amlodipine in Patients With Hypertension [Phase 3]
Phase 3 study evaluating LCZ696 (sacubitril/valsartan) alone and with amlodipine for hypertension has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2014-07-04Clinical Trial Update: Effects of Intralipid Versus Olive Oil Infusions on Endothelial Function, Immune Function, Inflammatory Markers [Phase 2, Phase 3]
Emory University-sponsored Phase 2/3 trial evaluating intralipid versus olive oil lipid infusions, intended to assess endothelial function, …
-
CLINICAL_TRIALS withdrawal · 2014-05-28Clinical Trial Update: Spironolactone Versus Amiloride as an Add on Agent in Resistant Hypertension [NA]
Clinical trial comparing spironolactone versus amiloride as add-on therapy in resistant hypertension has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2014-04-04Clinical Trial Update: Where Should Automated Blood Pressures be Done in Primary Care Offices?
A clinical trial evaluating where automated blood pressure measurements should be taken in primary care offices has been withdrawn.
-
EMA withdrawal · 2014-04-02EMA Withdrawn: Onduarp (telmisartan) — Boehringer Ingelheim International GmbH
The EMA withdrew Onduarp (telmisartan) from Boehringer Ingelheim International GmbH, with the decision in 2014, in the hypertension therapeu…
-
CLINICAL_TRIALS withdrawal · 2014-02-11Clinical Trial Update: Irbesartan Versus Amlodipine: The OBI Study [Phase 4]
This Phase 4 clinical trial comparing irbesartan to amlodipine (the OBI study) has been withdrawn. The study enrolled patients with obesity …
-
CLINICAL_TRIALS withdrawal · 2014-01-28Clinical Trial Update: Improving Medication Adherence in Hypertensive Patients [NA]
A Duke University-sponsored clinical trial aimed at improving medication adherence in hypertension has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2014-01-08Clinical Trial Update: Vitamin D and Blood Pressure [NA]
A clinical trial investigating Vitamin D for hypertension was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-11-18Clinical Trial Update: The Study of Novel Dual Renin Angiotensin Aldosterone System (RAAS) Blockade; Valsartan/Aliskiren in African American Patients With Hypertension and the Metabolic Syndrome [Phase 1]
Phase 1 clinical trial of dual RAAS blockade with valsartan and aliskiren in African American patients with hypertension and metabolic syndr…
-
CLINICAL_TRIALS withdrawal · 2013-10-01Clinical Trial Update: A Novel Non-interfering Arterial Blood Pressure Monitoring Device [NA]
A clinical trial evaluating Sense A/S's novel non-interfering arterial blood pressure monitoring device has been withdrawn. The study involv…
-
CLINICAL_TRIALS withdrawal · 2013-07-29Clinical Trial Update: The Evaluation of Clevidipine in Patients Requiring ICP Monitoring and IV Antihypertensive Therapy [Phase 4]
A Phase 4 clinical trial evaluating clevidipine for hypertension in patients requiring intracranial pressure monitoring has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-05-30Clinical Trial Update: Post Kidney Transplant Nocturnal Hypertension Prevalence and Management Study [NA]
The trial evaluating nocturnal hypertension in kidney transplant recipients was withdrawn from the registry.
-
CLINICAL_TRIALS withdrawal · 2013-05-14Clinical Trial Update: Safety And Efficacy Of Spirinolactone Plus Hydroflumethiazide In The Treatment Of Filipino Patients With Hypertension
Pfizer-sponsored clinical trial evaluating spironolactone plus hydroflumethiazide for hypertension in Filipino patients has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-04-17Clinical Trial Update: Sympathetic Overactivity in Essential Hypertension
A clinical trial investigating sympathetic overactivity in essential hypertension and related proteinuria has been withdrawn.
-
EMA withdrawal · 2013-03-01EMA Withdrawn: Riprazo (aliskiren) — Novartis Europharm Ltd.
EMA has withdrawn Riprazo (aliskiren) from the market in Europe.
-
CLINICAL_TRIALS withdrawal · 2012-11-16Clinical Trial Update: Adalat XL vs Diltiazem on Proteinuria and Blood Pressure in Hypertensive Diabetic Patients [Phase 3]
A Phase 3 trial comparing Adalat XL to Diltiazem in hypertensive patients with diabetic nephropathy has been withdrawn.
-
EMA withdrawal · 2012-10-22EMA Lapsed: Imprida HCT (amlodipine;valsartan;hydrochlorothiazide) — Novartis Europharm Ltd.
The EMA lists Imprida HCT (amlodipine; valsartan; hydrochlorothiazide) as lapsed, with hypertension as the therapeutic area.